ArticleSurgery today2018

The investigation of the survival time after recurrence in patients with pancreatic ductal adenocarcinoma for individualization of adjuvant chemotherapy.

Daisaku Yamada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.